Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

AYA-PeerConnect: Una Intervención de Coaching de Comunicación para Adolescentes/Jóvenes Adultos Sobrevivientes de Cáncer (AYACS)

2 de noviembre de 2026 actualizado por: Pooja Rao, Milton S. Hershey Medical Center

AYA-PeerConnect: Una Intervención de Coaching en Comunicación para Adolescentes/Jóvenes Adultos Supervivientes de Cáncer (AJASC)

This research is being done to test a communication coaching intervention pilot designed to improve communication quality between adolescent/young adult cancer survivors (AYACS) and their friends/peers. The results of the study will help to understand how to best support adolescent/young adult cancer survivors, and may inform the development or future implementation of similar programs for cancer survivor populations.

Descripción general del estudio

Descripción detallada

This study is being done to test a communication coaching intervention designed to improve communication quality between adolescent/young adult cancer survivors (AYACS) and their friends/peers. The results of the study will help to understand how to best support adolescent/young adult cancer survivors, and may inform the development or future implementation of similar programs for cancer survivor populations.

Tipo de estudio

Intervencionista

Inscripción (Actual)

11

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Pennsylvania
      • Hershey, Pennsylvania, Estados Unidos, 17033
        • Milton S. Hershey Medical Center

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 35 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Participant is currently ≥18-35 years old
  • Participant is receiving cancer-directed care at Penn State Cancer Institute or Penn State Children's Hospital
  • Participant has completed all cancer-directed therapy and is at least 1 year from end of cancer treatment (based on date of last cancer-directed treatment)
  • Participant has access to a computer with internet capability
  • Participant is fluent in written and spoken English

Exclusion Criteria:

  • Participant is not fluent in written and spoken English
  • Participant with cognitive inability to participant in the study as determined by the study team
  • Participants with history of relapsed cancer

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Asynchronous coaching and artificial intelligence (AI) Yoodli coach sessions

The intervention will use a combination of asynchronous communication coaching sessions, and AI Yoodli coach sessions.

Participants will complete asynchronous individual sessions for Visits 2-4. Each visit will include a 60-minute interactive didactic session using Rise 360 software, with a 20-minute Yoodli AI coaching session (both Rise 360 and Yoodli will be accessed via website). Rise 360 sessions will cover topics related to communication style, multiple goals theory and how to apply concepts learned in being good communicators. Yoodli AI coaching session will be completed for the corresponding Rise 360 session before moving to the next visit's session.

The 20-minute Yoodli AI coaching sessions will include coaching from the Yoodli AI coach and practicing various peer conversation situations. These sessions will consolidate and reinforce concepts learned in the didactic sessions. The Yoodli AI coach is programmed with input on relationship style (a communication tool to assess communication style) to deliver personalized coaching.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Intervention Feasibility (Quantitative)
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Quantitative feasibility will be collected based on visit attendance.

Post intervention follow up visit (Up to a month)
Intervention Feasibility (Qualitative)
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Qualitative feasibility data will be collected from post-module mixed methods assessments, and exit interviews and focus groups.

Post intervention follow up visit (Up to a month)
Intervention Acceptability (Quantitative)
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Quantitative acceptability will be collected using an acceptability questionnaire. Quantitative acceptability will be integrated with qualitative data from post-module mixed methods assessments, and exit interviews and focus groups to understand intervention acceptability.

Post intervention follow up visit (Up to a month)
Intervention Acceptability (Qualitative)
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Qualitative acceptability data will be collected from post-module mixed methods assessments, and exit interviews and focus groups.

Post intervention follow up visit (Up to a month)
Communication quality Multiple Goals Score
Periodo de tiempo: Baseline

Rating process for communication quality analysis (CQA) domains. A domain score is calculated for each of the six communication quality domains (content, emotion, accommodation, engagement, relationship, and face). Using the emotion domain as an example, the neutral score is assigned as a "1," and as participants express emotion (as per the definition above and further detailed in the CQA codebook) the score increases with the highest quality score being "7". A domain score is assigned every five minutes for each of the six domains. The full range for each measure is 6 (most neutral)-42 (highest quality).

Baseline
Communication quality Multiple Goals Score
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Rating process for communication quality analysis (CQA) domains. A domain score is calculated for each of the six communication quality domains (content, emotion, accommodation, engagement, relationship, and face). Using the emotion domain as an example, the neutral score is assigned as a "1," and as participants express emotion (as per the definition above and further detailed in the CQA codebook) the score increases with the highest quality score being "7". A domain score is assigned every five minutes for each of the six domains. The full range for each measure is 6 (most neutral)-42 (highest quality).

Post intervention follow up visit (Up to a month)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Anxiety
Periodo de tiempo: Baseline

Anxiety will be measured using the Anxiety (Emotional Distress-Anxiety-Short Form 8a) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item self-report questionnaire assessing anxiety symptoms over the past 7 days, including fear, tension, and worry. It is scored on a 5-point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always).

Baseline
Anxiety
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Anxiety will be measured using the Anxiety (Emotional Distress-Anxiety-Short Form 8a) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item self-report questionnaire assessing anxiety symptoms over the past 7 days, including fear, tension, and worry. It is scored on a 5-point Likert scale (1=Never, 2=Rarely, 3=Sometimes, 4=Often, 5=Always).

Post intervention follow up visit (Up to a month)
Depression
Periodo de tiempo: Baseline

Depression will be measured using the Depression (Emotional Distress-Depression-Short Form 8b) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item, self-report questionnaire assessing negative mood, views of self, and social cognition over the past seven days. It uses a 5-point scale (1=Never, 5=Always) to measure severity.

Baseline
Depression
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Depression will be measured using the Depression (Emotional Distress-Depression-Short Form 8b) measure from the Patient Reported Outcomes Measurement Information System (PROMIS). It is an 8-item, self-report questionnaire assessing negative mood, views of self, and social cognition over the past seven days. It uses a 5-point scale (1=Never, 5=Always) to measure severity.

Post intervention follow up visit (Up to a month)
Social isolation
Periodo de tiempo: Baseline

Social isolation will be measured by the validated Patient Reported Outcomes Measurement Information System (PROMIS) Social Isolation Form 8a.The PROMIS Social Isolation 8a short form is a 8-item, self-report tool measuring perceived loneliness and detachment from others. It uses a 5-point Likert scale (1=Never to 5=Always) to assess feelings of being avoided, excluded, or disconnected.

Baseline
Social isolation
Periodo de tiempo: Post intervention follow up visit (Up to a month)

Social isolation will be measured by the validated Patient Reported Outcomes Measurement Information System (PROMIS) Social Isolation Form 8a.The PROMIS Social Isolation 8a short form is a 8-item, self-report tool measuring perceived loneliness and detachment from others. It uses a 5-point Likert scale (1=Never to 5=Always) to assess feelings of being avoided, excluded, or disconnected.

Post intervention follow up visit (Up to a month)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Pooja Rao, MD MSCE, Penn State College of Medicine

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

14 de abril de 2026

Finalización primaria (Actual)

13 de mayo de 2026

Finalización del estudio (Actual)

4 de septiembre de 2026

Fechas de registro del estudio

Enviado por primera vez

2 de marzo de 2026

Primero enviado que cumplió con los criterios de control de calidad

2 de marzo de 2026

Publicado por primera vez (Actual)

6 de marzo de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

3 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

2 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Aggregate participant data that underlie the results reported in the study, after de-identification.

Marco de tiempo para compartir IPD

1 years to 3 years following final publication.

Tipo de información de apoyo para compartir IPD

  • PROTOCOLO DE ESTUDIO
  • CIF

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir